Equine Performance Labs Announces Publication of Landmark Study in BMC Medicine Demonstrating Safety, Consistency, and Clinical Promise of equicent™ CTM Umbilical Cord Allograft
Equine Performance Labs (EPL) is proud to announce the publication of a pivotal peer-reviewed study in BMC Medicine ("Cryopreserved equine umbilical cord tissue allograft characterization and biocompatibility in vivo in musculoskeletal tissues: a controlled study"), highlighting the safety, consistency, and biological innovation of its proprietary injectable allograft, equicent™ CTM, for equine musculoskeletal repair.[1][2]
